Barclays Adjusts Price Target#

Barclays has lowered its price target for Sunrun Inc. shares from $23 to $14 while maintaining an Equalweight rating. This change comes as the stock has seen a significant decline of 40% over the past six months, currently trading at $12.18. Despite this drop, some analyses suggest that the shares may still be undervalued based on their Fair Value assessment.

Anticipated First Quarter Results#

The firm expects that Sunrun's upcoming first quarter results will reflect the effects of affiliate cuts and seasonal declines in volume. Seasonal volume refers to fluctuations in business activity that occur at different times of the year, which can impact sales and revenue.

Reliance on Asset Sales#

Barclays also indicated that Sunrun may need to rely more on asset sales in 2026 to counteract weaknesses in tax equity financing. Tax equity financing involves investors providing capital in exchange for tax benefits, which can be crucial for companies in the renewable energy sector.

Focus on Debt Management#

The analyst noted that Sunrun is prioritizing reducing its debt and addressing safe harboring concerns over returning capital to shareholders in the near term. Currently, Sunrun has a high debt-to-equity ratio of 4.74 and total debt of $14.8 billion, indicating that the company has significantly more debt than equity. This focus on managing debt is critical for the company's financial health.

Recent Analyst Revisions#

In related news, Sunrun reported fourth-quarter revenue of $1,158.6 million, a 124% increase year-over-year, surpassing expectations. Following this report, several analysts adjusted their outlooks on the company. For instance, Freedom Capital Markets downgraded Sunrun to Hold and reduced its price target to $12.00. Jefferies also lowered its target to $15, while GLJ Research significantly cut its target to $4.63, reiterating a Sell rating. Conversely, UBS raised its price target to $23, maintaining a Buy rating, reflecting diverse perspectives on Sunrun's future performance.